Brecanavir
Alternative Names: 640385; GW 0385; GW 640385; VX-385Latest Information Update: 02 Jul 2023
At a glance
- Originator Vertex Pharmaceuticals
- Developer GSK; Vertex Pharmaceuticals
- Class Antiretrovirals
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 18 Dec 2006 Discontinued - Phase-II for HIV infections treatment in Australia (unspecified route)
- 18 Dec 2006 Discontinued - Phase-II for HIV infections treatment in Canada (unspecified route)
- 18 Dec 2006 Discontinued - Phase-II for HIV infections treatment in European Union (unspecified route)